Nanodelivery of Nitazoxanide: Impact on the Metabolism of Taenia Crassiceps Cysticerci Intracranially Inoculated in Mice

References

• Maurice J . Of pigs and people – WHO prepares to battle cysticercosis. Lancet384(9943), 571–572 (2014).
   Web of Science ®Google Scholar
• Garcia HH , DelBrutto OH. Cysticercosis Working Group in Peru. Antiparasitic treatment of neurocysticercosis – the effect of cyst destruction in seizure evolution. Epilepsy Behav.76, 158–162 (2017).
   PubMed Web of Science ®Google Scholar
• Devleesschauwer B , AllepuzA , DermauwVet al. Taenia solium in Europe: still endemic? Acta Trop. 165, 96–99 (2017).
   PubMed Web of Science ®Google Scholar
• Weka R , KamaniJ , CoganTet al. Overview of Taenia solium cysticercosis in West Africa. Acta Trop.190, 329–338 (2019).
   PubMed Web of Science ®Google Scholar
• García HH , EvansCAW , NashTEet al. Current consensus guidelines for treatment of neurocysticercosis. Clin. Microbiol. Rev.15(4), 747–756 (2002).
   PubMed Web of Science ®Google Scholar
• Palomares-Alonso F , PiliadoJC , PalenciaGet al. Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts. J. Antimicrob. Chemother.59(2), 212–218 (2007).
   PubMed Web of Science ®Google Scholar
• Leonardi D , EcheniqueC , LamasMCet al. High efficacy of albendazole-PEG 6000 in the treatment of Toxocara canis larva migrans infection. J. Antimicrob. Chemother.64(2), 375–378 (2009).
   PubMed Web of Science ®Google Scholar
• Gonzalez MA , RamírezRigo MV , GonzalezVidal NL. Praziquantel systems with improved dissolution rate obtained by high pressure homogenization. Mater. Sci. Eng. C Mater. Biol. Appl.93, 28–35 (2018).
   PubMed Web of Science ®Google Scholar
• Ali H , SinghSK. Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine. Ther. Deliv.7(1001), 691–709 (2016).
   PubMedGoogle Scholar
• Islan GA , DuránM , CacicedoMLet al. Nanopharmaceuticals as a solution to neglected diseases: is it possible? Acta Trop. 170, 16–42 (2017).
   PubMed Web of Science ®Google Scholar
• Taghipour-Sabzevar V , SharifiT , MoghaddamMM. Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents. Ther. Deliv.10(8), 527–550 (2019).
   PubMed Web of Science ®Google Scholar
• Arrúa EC , SeremetaKP , BedogniGRet al. Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of Chagas disease: a review. Acta Trop.198, 105080 (2019).
   PubMed Web of Science ®Google Scholar
• Scherließ R . Future of nanomedicines for treating respiratory diseases. Expert Opin. Drug Deliv.16(1), 59–68 (2019).
   PubMed Web of Science ®Google Scholar
• Ashour DS . Ivermectin: from theory to clinical application. Int. J. Antimicrob. Agents54(2), 134–142 (2019).
   PubMed Web of Science ®Google Scholar
• Puttappa N , SureshKumar R , KuppusamyGet al. Nano-drug delivery strategies in the treatment of plasmodium infection. Acta Trop.195, 103–114 (2019).
   PubMed Web of Science ®Google Scholar
• White AC Jr . Nitazoxanide: an important advance in anti-parasitic therapy. Am. J. Trop. Med. Hyg.68(4), 382–383 (2003).
   PubMed Web of Science ®Google Scholar
• White AC Jr . Nitazoxanide: a new broad spectrum antiparasitic agent. Expert Rev. Anti. Infect. Ther.2(1), 43–49 (2004).
   PubMedGoogle Scholar
• Lateef M , ZargarSA , KhanARet al. Successful treatment of niclosamide- and praziquantel-resistant beef tapeworm infection with nitazoxanide. Int. J. Infect. Dis.12(1), 80–82 (2008).
   PubMed Web of Science ®Google Scholar
• Singh PK , AjayA , KushwahaSet al. Towards novel antifilarial drugs: challenges and recent developments. Future Med. Chem.2(2), 251–283 (2010).
   PubMed Web of Science ®Google Scholar
• Rossignol JF . Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus. J. Infect. Public. Health.9(3), 227–230 (2016).
   PubMed Web of Science ®Google Scholar
• Rossignol JF . Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antiviral Res.110, 94–103 (2014).
   PubMed Web of Science ®Google Scholar
• Dang W , XuL , MaBet al. Nitazoxanide inhibits human norovirus replication and synergizes with ribavirin by activation of cellular antiviral response. Antimicrob. Agents Chemother.62(11), e00707–e00718 (2018).
   PubMed Web of Science ®Google Scholar
• Miyamoto Y , EckmannL. Drug development against the major diarrhea-causing parasites of the small intestine, Cryptosporidium and Giardia. Front. Microbiol.6, 1208 (2015).
   PubMed Web of Science ®Google Scholar
• Dhawan AK , BisherwalK , GandhiVet al. Successful treatment of cutaneous leishmaniasis with nitazoxanide. Indian J. Dermatol. Venereol. Leprol.81(6), 644–646 (2015).
   PubMedGoogle Scholar
• Gilles HM , HoffmanPS. Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends Parasitol.18(3), 95–97 (2002).
   PubMed Web of Science ®Google Scholar
• Vaz AJ , NunesCM , PiazzaRMet al. Immunoblot with cerebroespinal fluid from patients with neurocysticercosis using antigen from cysticerci of Taenia solium and Taenia crassiceps. Am. J. Trop. Med. Hyg.57(3), 354–357 (1997).
   PubMed Web of Science ®Google Scholar
• Vinaud MC , LinoJunior RS , BezerraJCB. Taenia crassiceps organic acids detected in cysticerci. Exp. Parasitol.116(4), 335–339 (2007).
   PubMed Web of Science ®Google Scholar
• Lightowlers MW . Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine. Parasite Immunol.32(11–12), 701–709 (2010).
   PubMed Web of Science ®Google Scholar
• Real D , HoffmannS , LeonardiDet al. Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations. PLoS ONE.13(12), e0207625 (2018).
   PubMed Web of Science ®Google Scholar
• Jurišić Dukovski B , JuretićM , BračkoDet al. Functional ibuprofen-loaded cationic nanoemulsion: development and optimization for dry eye disease treatment. Int. J. Pharm.25(576), 118979 (2020).
   Google Scholar
• Game MD , SakarkarDM. Simultaneous spectrophotometric estimation of nitazoxanide and ofloxacin in tablets. Indian J. Pharm. Sci.73(1), 70–74 (2011).
   PubMed Web of Science ®Google Scholar
• Yuksel N , KanikAE , BaykaraT. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int. J. Pharm.209(1–2), 57–67 (2000).
   PubMed Web of Science ®Google Scholar
• Zhang Y , HuoM , ZhouJet al. DDSolver: an Add-In program for modeling and comparison of drug dissolution profiles. J. AAPS12(3), 263–271 (2010).
   PubMed Web of Science ®Google Scholar
• Matos-Silva H , ReciputtiBP , PaulaECet al. Experimental encephalitis caused by Taenia crassiceps cysticerci in mice. Arq. Neuropsiq.70(4), 287–292 (2012).
   PubMed Web of Science ®Google Scholar
• Vinaud MC , FerreiraCS , LinoJunior RSet al. Taenia crassiceps: fatty acids oxidation and alternative energy source in in vitro cysticerci exposed to antihelminthic drugs. Exp. Parasitol.122(3), 208–211 (2009).
   PubMed Web of Science ®Google Scholar
• Fraga CM , CostaTL , BezerraJCet al. Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci. Exp. Parasitol.130(2), 146–151 (2012).
   PubMed Web of Science ®Google Scholar
• Calvo P , Remuñán-LópezC , Vila-JatoJLet al. Development of positively charged colloidal drug carriers: chitosan-coated polyester nanocapsules and submicron-emulsions. Colloid Polym. Sci.275, 46–53 (1997).
   Web of Science ®Google Scholar
• Đorđević SM , CekićND , SavićMMet al. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: design, characterization and in vivo pharmacokinetic evaluation. Int. J. Pharm.493(1–2), 40–54 (2015).
   PubMedGoogle Scholar
• Anderson VR , CurranMP. Nitazoxanide: a review of its use in the treatment of gastrointestinal infections. Drugs67(13), 1947–1967 (2007).
   PubMed Web of Science ®Google Scholar
• El-Kowrany SI , ElGhaffar AEA , ShoheibZSet al. Evaluation of nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis. Acta Trop.195, 145–154 (2019).
   PubMed Web of Science ®Google Scholar
• Ruiz-Olmedo MI , Gallegos-PerezJL , Calderon-GonzalezKGet al. Sensitive high performance liquid chromatographic assay for nitazoxanide metabolite in plasma. Pharmazie64(7), 419–422 (2009).
   PubMed Web of Science ®Google Scholar
• Suresh K , MannavaMK , NangiaA. Cocrystals and alloys of nitazoxanide: enhanced pharmacokinetics. Chem. Commun.52(22), 4223–4226 (2016).
   PubMed Web of Science ®Google Scholar
• Jara MO , Catalan-FigueroaJ , LandinMet al. Finding key nanoprecipitation variables for achieving uniform polymeric nanoparticles using neurofuzzy logic technology. Drug Deliv. Transl. Res.8(6), 1797–1806 (2018).
   PubMed Web of Science ®Google Scholar
• Seremeta KP , ArrúaEC , OkulikNBet al. Development and characterization of benznidazole nano- and microparticles: a new tool for pediatric treatment of Chagas disease? Colloids Surf. B Biointerfaces 177, 169–177 (2019).
   PubMed Web of Science ®Google Scholar
• Anton N , VandammeTF. Nano-emulsions and micro-emulsions: clarifications of the critical differences. Pharm. Res.28(5), 978–985 (2011).
   PubMed Web of Science ®Google Scholar
• Erdoğar N , AkkınS , BilensoyE. Nanocapsules for drug delivery: an updated review of the last decade. Recent Pat. Drug Deliv. Formul.12(4), 252–266 (2018).
   PubMedGoogle Scholar
• Hafner A , LovrićJ , VoinovichDet al. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. Int. J. Pharm.381(2), 205–213 (2009).
   PubMed Web of Science ®Google Scholar
• Ceña V , JátivaP. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases. Nanomedicine13(13), 1513–1516 (2018).
   PubMed Web of Science ®Google Scholar
• Gandhi H , SharmaAK , MahantSet al. Recent advancements in brain tumor targeting using magnetic nanoparticles. Ther. Deliv.11(2), 97–112 (2020).
   PubMed Web of Science ®Google Scholar
• Rodrigues SF , FielLA , ShimadaALet al. Lipid-core nanocapsules act as a drug shuttle through the blood brain barrier and reduce glioblastoma after intravenous or oral administration. J. Biomed. Nanotechnol.12(5), 986–1000 (2016).
   PubMed Web of Science ®Google Scholar
• Montenegro L , ParentiC , TurnaturiRet al. Resveratrol-loaded lipid nanocarriers: correlation between in vitro occlusion factor and in vivo skin hydrating effect. Pharmaceutics9(4), E58 (2017).
   PubMed Web of Science ®Google Scholar
• Abbasalipourkabir R , FallahM , SedighiFet al. Nanocapsulation of nitazoxanide in solid lipid nanoparticles as a new drug delivery system and in vitro release study. J. Biol. Sci.16(4), 120–127 (2016).
   Google Scholar
• Omwenga EO , HenselA , ShitandiAet al. Chitosan nanoencapsulation of flavonoids enhances their quorum sensing and biofilm formation inhibitory activities against an E. coli Top 10 biosensor. Colloids Surf. B Biointerfaces.164, 125–133 (2018).
   PubMed Web of Science ®Google Scholar
• Neves AR , LúcioM , MartinsSet al. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int. J. Nanomedicine8, 177–187 (2013).
   PubMed Web of Science ®Google Scholar
• Yukuyama MN , GhisleniDD , PintoTJet al. Nanoemulsion: process selection and application in cosmetics – a review. Int. J. Cosmet. Sci.38, 13–24 (2016).
   PubMed Web of Science ®Google Scholar
• Fontana MC , CoradiniK , PohlmannARet al. Nanocapsules prepared from amorphous polyesters: effect on the physicochemical characteristics, drug release, and photostability. J. Nanosci. Nanotechnol.10(5), 3091–3099 (2010).
   PubMed Web of Science ®Google Scholar
• Sonvico F , CagnaniA , RossiAet al. Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction. Int. J. Pharm.324(1), 67–73 (2006).
   PubMed Web of Science ®Google Scholar
• Azadi S , AshrafiH , AzadiA. Mathematical modeling of drug release from swellable polymeric nanoparticles. J. Appl. Pharm. Sci.7(04), 125–133 (2017).
   Google Scholar
• Zhang L , YangL , ZhangXet al. Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: influence of in vitro release, treatment interval and dose. J. Control. Rel.283, 163–174 (2018).
   PubMed Web of Science ®Google Scholar
• Nasareth JM , FragaCM , LimaNFet al. In vivo treatment with nitazoxanide induces anaerobic metabolism in experimental intraperitoneal cysticercosis. Parasitol. Res.116(11), 3037–3041 (2017).
   PubMed Web of Science ®Google Scholar
• Lima NF , PicançoGA , AlvesDSMMet al. Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci. Acta Trop.190, 361–364 (2019).
   PubMed Web of Science ®Google Scholar
• Tielens AGM Van Hellemond JJ . Unusual aspects of metabolism in flatworm parasites. In: Parasitic Flatworms: Molecular Biology, Biochemistry, Immunology and Physiology.MauleAG, MarksNJ ( Eds). CABI, London, UK, 387–407 (2005).
   Google Scholar